SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) off
The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): October 16, 2017
GENUFOOD ENERGY ENZYMES CORP.
(Exact name of registrant as specified
|(State or other jurisdiction of incorporation)
||(Commission File Number)
||(IRS Employer Identification No.)|
601 South Figueroa Street,
Los Angeles, California
|(Address of principal executive offices)
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
It has come to the attention of Genufood Energy Enzymes Corp.
(the “Company”) that the telephone number listed on the Company’s filing with the SEC is incorrect. The correct
telephone number should be (213) 337-6770.
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
||GENUFOOD ENERGY ENZYMES CORP.
|Date: October 18, 2017
||/s/ Yi Ling Chen
||Yi Ling Chen, Director